Newstral
Article
Ars Technica on 2023-10-18 00:16
COVID antiviral Paxlovid to see price increase following 400% vaccine hike
Related news
- Moderna CEO: 400% price hike on COVID vaccine “consistent with the value”Ars Technica
- Pfizer more than doubles price of life-saving COVID antiviral, PaxlovidArs Technica
- Coronavirus treatment: WHO recommends antiviral pill PaxlovidThe Times of India
- Administration Expands Availability of Covid Antiviral Pill Paxlovidlongislandpress.com
- How to get COVID-19 antiviral pills like PaxlovidSeattle Times
- Coronavirus: Pfizer’s Paxlovid antiviral lowers long-Covid risk, study findsSouth China Morning Post
- TOntario receives first shipment of antiviral COVID-19 drug Paxlovidtorontosun.com
- FDA Allows Pharmacists to Prescribe the COVID-19 Antiviral Paxlovidjdsupra.com
- BPfizer Brought Us a Covid Vaccine and Paxlovid. Here’s What’s Next.1 min readbarrons.com
- Moderna rakes in surprise profits ahead of 400% vaccine price hikeArs Technica
- MWhat is Paxlovid, Pfizer’s COVID antiviral drug, and how effective is it?5 min readmarketwatch.com
- Biden administration moves to make COVID-19 antiviral drug Paxlovid more availableLA Times
- COVID-19 antiviral drug Paxlovid being dispensed at low rates across CanadaThe Globe and Mail
- Concerns grow that COVID-19 may ‘rebound’ after taking antiviral PaxlovidSan Jose Mercury News
- MHow does Paxlovid work? Here’s what to know about the COVID antiviral medicationmcclatchydc.com
- A Paxlovid primer: What to know about new oral antiviral treatment for COVID-19Vancouver Sun
- Drugmakers Promise Investors They'll Soon Hike Covid Vaccine PricesThe Intercept
- Yes, Pfizer is planning to increase the cost of its COVID-19 vaccine by as much as 400%rssfeeds.king5.com